Apatinib for salvage treatment of advanced malignant pleural mesothelioma: A case report

RATIONALE: Malignant Pleural Mesothelioma (MPM) is rare cancer and has a poor prognosis with resistance to chemotherapy or radiotherapy. Until now there is no standard third-line treatment for patients who have failed second-line therapy. PATIENT CONCERNS: A 58-year-old non-smoking female peasant of...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Zedong, Yu, Yanxin, Wu, Dajun, Zhang, Guangyu, Wang, Yang, He, Liang, Meng, RongQin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250491/
https://www.ncbi.nlm.nih.gov/pubmed/30407323
http://dx.doi.org/10.1097/MD.0000000000013105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250491/
https://www.ncbi.nlm.nih.gov/pubmed/30407323
http://dx.doi.org/10.1097/MD.0000000000013105

Ejemplares similares